Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy. Biotechnology and Bioengineering, Drugs (Pharmaceuticals), China Read More

Leave a Comment

Your email address will not be published. Required fields are marked *